Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyanshankar P Mishra

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Lancet. Infectious Diseases|November 24, 2012
Public-private mix in tuberculosisGyanshankar P Mishra
The Lancet. Infectious Diseases|August 27, 2011
Treatment of drug-resistant tuberculosisGyanshankar P Mishra
The Lancet. Respiratory Medicine|November 29, 2020
Corticosteroids for COVID-19: the search for an optimum duration of therapyGyanshankar P Mishra, Jasmin Mulani
The Lancet. Infectious Diseases|January 31, 2017
Patients with tuberculosis in the private sector: counting the uncountedGyanshankar P Mishra, Jasmin Mulani
The Lancet. Infectious Diseases|January 29, 2022
Implications of bedaquiline-resistant tuberculosisGyanshankar P Mishra, Jasmin Mulani
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 23, 2018
Low-dose amoxicillin-clavulanate in drug-resistant tuberculosisGyanshankar P Mishra, Jose A Caminero
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Lancet. Infectious Diseases|November 24, 2012
Public-private mix in tuberculosisGyanshankar P Mishra
The Lancet. Infectious Diseases|August 27, 2011
Treatment of drug-resistant tuberculosisGyanshankar P Mishra
The Lancet. Respiratory Medicine|November 29, 2020
Corticosteroids for COVID-19: the search for an optimum duration of therapyGyanshankar P Mishra, Jasmin Mulani
The Lancet. Infectious Diseases|January 31, 2017
Patients with tuberculosis in the private sector: counting the uncountedGyanshankar P Mishra, Jasmin Mulani
The Lancet. Infectious Diseases|January 29, 2022
Implications of bedaquiline-resistant tuberculosisGyanshankar P Mishra, Jasmin Mulani
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 23, 2018
Low-dose amoxicillin-clavulanate in drug-resistant tuberculosisGyanshankar P Mishra, Jose A Caminero
Pageof 1